{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T12:38:52Z","timestamp":1791722332634,"version":"4.3.4"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T00:00:00Z","timestamp":1695686400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T00:00:00Z","timestamp":1695686400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100019266","name":"Korea Medical Device Development Fund","doi-asserted-by":"publisher","award":["RS-2020-KD000013"],"award-info":[{"award-number":["RS-2020-KD000013"]}],"id":[{"id":"10.13039\/100019266","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Nonalcoholic fatty liver disease (NAFLD) can lead to a prothrombotic state, which significantly burdens public healthcare systems. This study investigated the relationship between NAFLD and the incidence of venous thromboembolism (VTE) in Korea using National Health Insurance Service-National Sample Cohort 2.0 data. A population-based retrospective cohort analysis was conducted on 472,212 healthy individuals who underwent national health check-ups in Korea from 2009 to 2014. NAFLD was defined using the fatty liver index (FLI). Multivariate Cox proportional hazards regression models were used to analyze the association between FLI and VTE. Individuals were categorized into four quartiles according to FLI values (first quartile [Q1], 0\u20135.7; second quartile [Q2], 5.8\u201315.3; third quartile [Q3], 15.4\u201337.2; and fourth quartile [Q4],\u2009&gt;\u200937.2). The incidence of VTE tended to increase with increasing FLI values (Q1, 598 [0.5%]; Q2, 1,033 [0.9%]; Q3, 1,443 [1.2%]; and Q4, 1,425 [1.2%]). In the age- and sex-adjusted multivariate model, the hazard ratio (HR) (95% confidence interval [CI]) was 1.47 (1.33\u20121.62) for Q4 compared with Q1. After adjusting for clinical variables with <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.1 in the univariate analyses, the HR (95% CI) was 1.45 (1.30\u20121.62) for Q4 compared with Q1. FLI was related to VTE risk, as confirmed after adjusting for other risk factors.<\/jats:p>","DOI":"10.1038\/s41598-023-42963-9","type":"journal-article","created":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T10:02:56Z","timestamp":1695722576000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Association of nonalcoholic fatty liver disease and venous thromboembolic disease in healthy adults in Korea: a nationwide study"],"prefix":"10.1038","volume":"13","author":[{"given":"Chang-Yeon","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Namkyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae-Hyung","family":"Roh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,26]]},"reference":[{"issue":"2","key":"42963_CR1","doi-asserted-by":"publisher","first-page":"206","DOI":"10.5009\/gnl20127","volume":"15","author":"S Murag","year":"2021","unstructured":"Murag, S., Ahmed, A. & Kim, D. Recent epidemiology of nonalcoholic fatty liver disease. Gut Liver 15(2), 206\u2013216 (2021).","journal-title":"Gut Liver"},{"issue":"1","key":"42963_CR2","doi-asserted-by":"publisher","first-page":"S47","DOI":"10.1016\/j.jhep.2014.12.012","volume":"62","author":"CD Byrne","year":"2015","unstructured":"Byrne, C. D. & Targher, G. NAFLD: A multisystem disease. J. Hepatol. 62(1), S47\u2013S64 (2015).","journal-title":"J. Hepatol."},{"issue":"10","key":"42963_CR3","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1111\/jth.12698","volume":"12","author":"GE Raskob","year":"2014","unstructured":"Raskob, G. E. et al. Thrombosis: A major contributor to the global disease burden. J. Thromb. Haemost. 12(10), 1580\u20131590 (2014).","journal-title":"J. Thromb. Haemost."},{"issue":"4","key":"42963_CR4","doi-asserted-by":"publisher","first-page":"S495","DOI":"10.1016\/j.amepre.2009.12.017","volume":"38","author":"MG Beckman","year":"2010","unstructured":"Beckman, M. G., Hooper, W. C., Critchley, S. E. & Ortel, T. L. Venous thromboembolism. Am. J. Prev. Med. 38(4), S495\u2013S501 (2010).","journal-title":"Am. J. Prev. Med."},{"issue":"23","key":"42963_CR5","first-page":"748","volume":"107","author":"FA Anderson","year":"2003","unstructured":"Anderson, F. A. & Spencer, F. A. Risk factors for venous thromboembolism. Circulation 107(23), 748 (2003).","journal-title":"Circulation"},{"issue":"1","key":"42963_CR6","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3325\/cmj.2021.62.25","volume":"62","author":"L Virovic-Jukic","year":"2021","unstructured":"Virovic-Jukic, L., Stojsavljevic-Shapeski, S., Forgac, J., Kukla, M. & Mikolasevic, I. Non-alcoholic fatty liver disease\u2014a procoagulant condition?. Croat. Med. J. 62(1), 25\u201333 (2021).","journal-title":"Croat. Med. J."},{"issue":"2","key":"42963_CR7","doi-asserted-by":"publisher","first-page":"339","DOI":"10.14218\/JCTH.2021.00268","volume":"10","author":"D Ogresta","year":"2022","unstructured":"Ogresta, D. et al. Coagulation and endothelial dysfunction associated with NAFLD: Current status and therapeutic implications. J. Clin. Transl. Hepatol. 10(2), 339\u2013355 (2022).","journal-title":"J. Clin. Transl. Hepatol."},{"key":"42963_CR8","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3390\/biomedicines10020249","volume":"10","author":"A Tripodi","year":"2022","unstructured":"Tripodi, A. et al. Hypercoagulability in patients with non-alcoholic fatty liver disease (NAFLD): Causes and consequences. Biomedicines 10, 2 (2022).","journal-title":"Biomedicines"},{"issue":"1 Suppl","key":"42963_CR9","doi-asserted-by":"publisher","first-page":"S47","DOI":"10.1016\/j.jhep.2014.12.012","volume":"62","author":"CD Byrne","year":"2015","unstructured":"Byrne, C. D. & Targher, G. NAFLD: A multisystem disease. J. Hepatol. 62(1 Suppl), S47-64 (2015).","journal-title":"J. Hepatol."},{"issue":"9","key":"42963_CR10","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1016\/j.cgh.2010.05.014","volume":"8","author":"H Wu","year":"2010","unstructured":"Wu, H. & Nguyen, G. C. Liver cirrhosis is associated with venous thromboembolism among hospitalized patients in a nationwide US study. Clin. Gastroenterol. Hepatol. 8(9), 800\u2013805 (2010).","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"1","key":"42963_CR11","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/ajg.2008.34","volume":"104","author":"KK S\u00f8gaard","year":"2009","unstructured":"S\u00f8gaard, K. K. et al. Risk of venous thromboembolism in patients with liver disease: A nationwide population-based case-control study. Am. J. Gastroenterol. 104(1), 96\u2013101 (2009).","journal-title":"Am. J. Gastroenterol."},{"issue":"1","key":"42963_CR12","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1160\/TH16-06-0450","volume":"26","author":"PF Ambrosino","year":"2017","unstructured":"Ambrosino, P. F. et al. The risk of venous thromboembolism in patients with cirrhosis. A systematic review and meta-analysis. Thrombos. Haemost. 26(1), 139\u2013148 (2017).","journal-title":"Thrombos. Haemost."},{"key":"42963_CR13","doi-asserted-by":"publisher","first-page":"48","DOI":"10.3748\/wjg.v16.i48.6119","volume":"16","author":"MND Di-Minno","year":"2010","unstructured":"Di-Minno, M. N. D. High prevalence of nonalcoholic fatty liver in patients with idiopathic venous thromboembolism. World J. Gastroenterol. 16, 48 (2010).","journal-title":"World J. Gastroenterol."},{"key":"42963_CR14","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41424-018-0002-y","volume":"9","author":"JG Stine","year":"2018","unstructured":"Stine, J. G. et al. Increased risk of venous thromboembolism in hospitalized patients with cirrhosis due to non-alcoholic steatohepatitis. Clin. Transl. Gastroenterol. 9, 3 (2018).","journal-title":"Clin. Transl. Gastroenterol."},{"issue":"8","key":"42963_CR15","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1002\/lt.24134","volume":"21","author":"JG Stine","year":"2015","unstructured":"Stine, J. G. et al. Increased risk of portal vein thrombosis in patients with cirrhosis due to nonalcoholic steatohepatitis. Liver Transpl. 21(8), 1016\u20131021 (2015).","journal-title":"Liver Transpl."},{"key":"42963_CR16","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.thromres.2020.12.002","volume":"198","author":"A Ciavarella","year":"2021","unstructured":"Ciavarella, A. et al. Translational insight into prothrombotic state and hypercoagulation in nonalcoholic fatty liver disease. Thromb. Res. 198, 139\u2013150 (2021).","journal-title":"Thromb. Res."},{"issue":"2","key":"42963_CR17","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1182\/blood-2018-02-769000","volume":"132","author":"J Chen","year":"2018","unstructured":"Chen, J. & Chung, D. W. Inflammation, von Willebrand factor, and ADAMTS13. Blood 132(2), 141\u2013147 (2018).","journal-title":"Blood"},{"issue":"4","key":"42963_CR18","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1111\/j.1365-2141.2005.05753.x","volume":"131","author":"CT Esmon","year":"2005","unstructured":"Esmon, C. T. The interactions between inflammation and coagulation. Br. J. Haematol. 131(4), 417\u2013430 (2005).","journal-title":"Br. J. Haematol."},{"issue":"10","key":"42963_CR19","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1111\/j.1464-5491.2005.01646.x","volume":"22","author":"G Targher","year":"2005","unstructured":"Targher, G. et al. Non-alcoholic hepatic steatosis and its relation to increased plasma biomarkers of inflammation and endothelial dysfunction in non-diabetic men. Role of visceral adipose tissue. Diabet. Med. 22(10), 1354\u20131358 (2005).","journal-title":"Diabet. Med."},{"issue":"2","key":"42963_CR20","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1111\/j.1478-3231.2010.02375.x","volume":"31","author":"A Kotronen","year":"2011","unstructured":"Kotronen, A. et al. Increased coagulation factor VIII, IX, XI and XII activities in non-alcoholic fatty liver disease. Liver Int. 31(2), 176\u2013183 (2011).","journal-title":"Liver Int."},{"issue":"1","key":"42963_CR21","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1002\/hep.26510","volume":"59","author":"A Verrijken","year":"2014","unstructured":"Verrijken, A. et al. Prothrombotic factors in histologically proven nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Hepatology 59(1), 121\u2013129 (2014).","journal-title":"Hepatology"},{"issue":"1","key":"42963_CR22","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.jhep.2014.03.013","volume":"61","author":"A Tripodi","year":"2014","unstructured":"Tripodi, A. et al. Procoagulant imbalance in patients with non-alcoholic fatty liver disease. J. Hepatol. 61(1), 148\u2013154 (2014).","journal-title":"J. Hepatol."},{"key":"42963_CR23","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3390\/diagnostics11122233","volume":"11","author":"E-J Cho","year":"2021","unstructured":"Cho, E.-J. et al. Fatty liver index for predicting nonalcoholic fatty liver disease in an asymptomatic Korean population. Diagnostics 11, 12 (2021).","journal-title":"Diagnostics"},{"issue":"40","key":"42963_CR24","doi-asserted-by":"publisher","first-page":"e1682","DOI":"10.1097\/MD.0000000000001682","volume":"94","author":"X Huang","year":"2015","unstructured":"Huang, X. et al. Validation of the fatty liver index for nonalcoholic fatty liver disease in middle-aged and elderly Chinese. Medicine 94(40), e1682 (2015).","journal-title":"Medicine"},{"issue":"2","key":"42963_CR25","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.clnu.2019.02.024","volume":"39","author":"N Motamed","year":"2020","unstructured":"Motamed, N. et al. Fatty liver index (FLI) and prediction of new cases of non-alcoholic fatty liver disease: A population-based study of northern Iran. Clin. Nutr. 39(2), 468\u2013474 (2020).","journal-title":"Clin. Nutr."},{"key":"42963_CR26","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyv319","author":"J Lee","year":"2016","unstructured":"Lee, J., Lee, J. S., Park, S.-H., Shin, S. A. & Kim, K. Cohort profile: The National Health Insurance Service-National Sample Cohort (NHIS-NSC), South Korea. Int. J. Epidemiol. https:\/\/doi.org\/10.1093\/ije\/dyv319 (2016).","journal-title":"Int. J. Epidemiol."},{"issue":"1","key":"42963_CR27","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/1471-230X-6-33","volume":"6","author":"G Bedogni","year":"2006","unstructured":"Bedogni, G. et al. The Fatty Liver Index: A simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol. 6(1), 78 (2006).","journal-title":"BMC Gastroenterol."},{"issue":"17","key":"42963_CR28","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.1161\/CIRCULATIONAHA.105.169404","volume":"112","author":"SM Grundy","year":"2005","unstructured":"Grundy, S. M. et al. Diagnosis and management of the metabolic syndrome. Circulation 112(17), 2735\u20132752 (2005).","journal-title":"Circulation"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-42963-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-42963-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-42963-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T17:15:31Z","timestamp":1700414131000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-42963-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,26]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["42963"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-42963-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,26]]},"assertion":[{"value":"9 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"16069"}}